A phase Ia study of a novel anti-HER2 antibody–drug conjugate GQ1001 in patients with previously treated HER2 positive advanced solid tumors. - Zhou, Chenfei; Wang, Bin; Teng, Christina; Yang, Hui; Piha-Paul, Sarina A.; Richardson, Gary; Malalasekera, Ashanya; Sun, Yajun; Wang, Wei; Liu, Jieqiong; Shi, Yan; Zhan, Xianbao; et al. (Journal of Translational Medicine, 2025)